Synthesis and biological evaluation of analogues of butyrolactone I and molecular model of its interaction with CDK2
- 16 June 2004
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 2 (13) , 1864-1871
Abstract
A series of analogues of butyrolactone I, a natural product isolated from Aspergillus terreus that selectively inhibits the CDK2 and CDK1 kinases and that has been found to exhibit an interesting antiproliferative activity, have been synthesized. Its antitumor activity has been tested. Molecular models of the complex between butyrolactone I and the CDK2 active site have been built using a combination of conformational search and automated docking techniques. The stability of the resulting complexes has been assessed by molecular dynamics simulations and the experimental results obtained for the synthesized analogues are rationalized based on the molecular models.Keywords
This publication has 17 references indexed in Scilit:
- Implications of protein flexibility for drug discoveryNature Reviews Drug Discovery, 2003
- A Computational Model of Binding Thermodynamics: The Design of Cyclin-dependent Kinase 2 InhibitorsJournal of Medicinal Chemistry, 2003
- Small Molecules as Inhibitors of Cyclin‐Dependent KinasesAngewandte Chemie International Edition, 2003
- A Modified Synthesis of (±)-β-Aryllactic acidsSynthesis, 1992
- An unbounded systematic search of conformational spaceJournal of Computational Chemistry, 1991
- Semianalytical treatment of solvation for molecular mechanics and dynamicsJournal of the American Chemical Society, 1990
- Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanicsJournal of Computational Chemistry, 1990
- A new force field for molecular mechanical simulation of nucleic acids and proteinsJournal of the American Chemical Society, 1984
- Metabolic products of Aspergillus terreus. IX. Biosynthesis of butyrolactone derivatives isolated from strains IFO 8835 and 4100.Chemical and Pharmaceutical Bulletin, 1983
- Studies on the metabolic products of Aspergillus terreus. III. Metabolites of the strain IFO 8835. 1.Chemical and Pharmaceutical Bulletin, 1977